A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus Paclitaxel as Weekly Treatment of Relapsed Platinum-resistant Ovarian Cancer
PHASE3
A clinical study to evaluate the efficacy and safety of TQB2450 injection c...
To Evaluate the Efficacy and Safety of TQB3728 Tablets in Sequential Maintenance of TQB2450 Injection Therapy in Patients After Sequential or Concurrent Chemoradiation for Locally Advanced Non-small Cell Lung Cancer.
PHASE1
It's a Phase Ib/II clinical trial to evaluate the efficacy and safety of TQ...
Status
Unknown
Location
Cancer Hospital Affiliated to Shandong First Medical University
A Study of TQB2450 Injection Plus Chemotherapy Followed by TQB2450 Plus Anlotinib Versus Tislelizumab Plus Chemotherapy Followed by Tislelizumab in the Treatment of First-line Non-squamous Non-small Cell Lung Cancer(NSCLC).
PHASE3
This is Phase 3, randomized, open-label, parallel controlled study designed...
Status
Unknown
Location
Chinese Academy of Medical Sciences Cancer Hospital
Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ยฑ Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus.
PHASE2
This clinical study plans to enroll 69 endometrial cancer patients and 5-10...
A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus K Drug in the Treatment of First-line Non-small Cell Lung Cancer(NSCLC)
PHASE3
A clinical study to evaluate the efficacy and safety of TQB2450 injection c...